Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 17:18:409-422.
doi: 10.2147/CIA.S366155. eCollection 2023.

Clinical and Therapeutic Considerations for Older Adults with Head and Neck Cancer

Daniel R Dickstein #  1 , Ann E Powers #  2 , Dragan Vujovic  1 , Scott Roof  2 , Richard L Bakst  1
Affiliations
Review

Clinical and Therapeutic Considerations for Older Adults with Head and Neck Cancer

Daniel R Dickstein et al. Clin Interv Aging. .

Abstract

Approximately 30% of patients with head and neck squamous cell carcinoma (HNSCC) are at least 70 years of age, and this percentage is expected to increase as the population increases and lives longer. Elderly patients are underrepresented in head and neck oncology clinical trials, and there is minimal evidence on the management of HNSCC for this population. Subsequently, despite their best intentions, physicians may unknowingly recommend an ill-suited course of therapy, which may result in suboptimal oncological or functional outcomes or adverse events. Surgical approaches have the potential to carry a higher risk of morbidity and mortality in older adults, especially in patients with multiple comorbidities. Definitive radiation therapy treatment in patients with HNSCC frequently involves 7 weeks of daily radiation, sometimes with concurrent chemotherapy, and this demanding treatment can be difficult for older adult patients, which may lead to treatment interruptions, potential removal of concurrent systemic therapy, compromised outcomes, and diminished quality of life. There are clinical trials currently underway investigating altered fractionation regimens and novel, less toxic systemic treatments in this population. This review provides an overview of how best to approach an older adult with HNSCC, from initial work-up to treatment selection.

Keywords: elderly; geriatric; head and neck squamous cell carcinoma; hypofractionation; older adult; oropharynx.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Proposed work flow for therapeutic considerations for elderly patients with HNSCC.
See this image and copyright information in PMC

References

    1. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. doi:10.1002/ijc.31937 - DOI - PubMed
    1. Sikora AG, Toniolo P, DeLacure MD. The changing demographics of head and neck squamous cell carcinoma in the United States. Laryngoscope. 2004;114(11):1915–1923. doi:10.1097/01.mlg.0000147920.66486.bc - DOI - PubMed
    1. Hankey BF, Ries LA, Edwards BK. Surveillence, Epidemiology, and End Results Program. N.C. Institute; 2017. - PubMed
    1. Howlader N. SEER Cancer Statistics Review, 1975–2016. Bethesda, MD: National Cancer Institute; 2019.
    1. Gillison ML, Broutian T, Pickard RKL, et al. Prevalence of oral HPV infection in the United States, 2009–2010. JAMA. 2012;307(7):693–703. doi:10.1001/jama.2012.101 - DOI - PMC - PubMed